Cerebral blood flow (CBF) and transit time are essential biomarkers for assessing brain health. While dynamic susceptibility contrast (DSC) MRI has been widely applied to measure these metrics, it is limited in the pediatric population due to the need for contrast agents. Arterial spin labeling is a non-invasive and quantitative MR modality, and multi-delay ASL can measure CBF and transit time simultaneously. Although multi-delay ASL has been used in adult neuroimaging studies, its application in children requires investigation. Moyamoya disease, a progressive steno-occlusive cerebrovascular disorder, often manifests in childhood. In this work, we present a cohort study that examines multi-delay ASL and DSC MRI to characterize vascular hemodynamics in 22 pediatric patients. We evaluate CBF and transit time in different brain regions before and after revascularization surgeries. Results show that revascularization significantly increased CBF by 24% and 7.6%, respectively, as measured by ASL and DSC; it also significantly decreased transit time by 12% and 15%, indicating improved hemodynamics and metabolism. ASL and DSC results also showed significantly positive correlations in all brain regions. Thus, revascularization improved hemodynamics in pediatric moyamoya patients and shows that multi-delay ASL can effectively characterize CBF and transit time in the pediatric population.
HaraSKikutaJTakabayashiK, et al.
Decreased diffusivity along the perivascular space and cerebral hemodynamic disturbance in adult moyamoya disease. J Cereb Blood Flow Metab2024;
44: 1787–1800.
2.
MorshedRAAblaAAMurphD, et al.
Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: a single-center series. J Clin Neurosci2020;
79: 137–143.
3.
TeoMAbhinavKBell-StephensTE, et al.
Short- and long-term outcomes of moyamoya patients post-revascularization. J Neurosurg2022;
1: 1–11.
4.
ZhaoMYArmindoRDGaudenAJ, et al.
Revascularization improves vascular hemodynamics − a study assessing cerebrovascular reserve and transit time in moyamoya patients using MRI. J Cereb Blood Flow Metab2023;
43: 138–151.
5.
Fan AudreyPKhalighi MohammadMGuoJ, et al.
Identifying hypoperfusion in moyamoya disease with arterial spin labeling and an [15O]-water positron emission tomography/magnetic resonance imaging normative database. Stroke2019;
50: 373–380.
6.
AbhinavKFurtadoSVNielsenTH, et al.
Functional outcomes after revascularization procedures in patients with hemorrhagic moyamoya disease. Neurosurgery2020;
86: 257–265.
7.
OgohS.Relationship between cognitive function and regulation of cerebral blood flow. J Physiol Sci2017;
67: 345–351.
8.
WeijsRWJShkredovaDABrekelmansACM, et al.
Longitudinal changes in cerebral blood flow and their relation with cognitive decline in patients with dementia: Current knowledge and future directions. Alzheimers Dement2023;
19: 532–548.
9.
van DintherMHooghiemstraAMBronEE, et al.
Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment. Alzheimers Dement2024;
20: 136–144.
10.
WangJAlsopDCSongHK, et al.
Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med2003;
50: 599–607.
11.
TsujikawaTKimuraHMatsudaT, et al.
Arterial transit time mapping obtained by pulsed continuous 3D ASL imaging with multiple Post-Label delay acquisitions: comparative study with PET-CBF in patients with chronic occlusive cerebrovascular disease. Plos One2016;
11: e0156005.
12.
ØstergaardL.Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging2005;
22: 710–717.
13.
LinY-HKuoM-FLuC-J, et al.
Standardized MR perfusion scoring system for evaluation of sequential perfusion changes and surgical outcome of moyamoya disease. AJNR Am J Neuroradiol2019;
40: 260–266.
14.
HuangALeeC-WLiuH-M.Time to peak and full width at half maximum in MR perfusion: valuable indicators for monitoring moyamoya patients after revascularization. Sci Rep2021;
11: 479.
15.
GopinathGAslamMAnushaP.Role of magnetic resonance perfusion imaging in acute stroke: arterial spin labeling versus dynamic susceptibility contrast-enhanced perfusion. Cureus2022;
14: e23625.
16.
JeongHKimPHJungAY, et al.
Risk of acute kidney injury after contrast-enhanced MRI examinations in a pediatric population. Eur Radiol2025;
35: 4171–4179.
17.
CheeneySHEMaloneyEIyerRS.Safety considerations related to intravenous contrast agents in pediatric imaging. Pediatr Radiol2023;
53: 1352–1363.
18.
LindnerTBolarDSAchtenE, et al.
Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging. Magn Reson Med2023;
89: 2024–2047.
19.
AlsopDCDetreJAGolayX, et al.
Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the european consortium for ASL in dementia. Magn Reson Med2015;
73: 102–116.
20.
WoodsJGChappellMAOkellTW.Designing and comparing optimized pseudo-continuous arterial spin labeling protocols for measurement of cerebral blood flow. NeuroImage2020;
223: 117246.
21.
ZhaoMYFanAPChenDY-T, et al.
Using arterial spin labeling to measure cerebrovascular reactivity in moyamoya disease: insights from simultaneous PET/MRI. J Cereb Blood Flow Metab2022;
42: 1493–1506.
22.
World Medical Association.
World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. Jama2013;
310: 2191–2194.
23.
SteinbergGKGooderhamPA.Intracranial-extracranial bypass surgery for moyamoya disease. In: KalaniYNakajiPSpetzlerRF (eds) Neurovascular surgery.
New York:
Thieme, 2015, pp. 1156–1171.
24.
ClementPMutsaertsH-JVáclav ůL, et al.
Variability of physiological brain perfusion in healthy subjects – a systematic review of modifiers. Considerations for multi-center ASL studies. J Cereb Blood Flow Metab2018;
38: 1418–1437.
25.
ChappellMAKirkTFCraigMS, et al.
BASIL: a toolbox for perfusion quantification using arterial spin labelling. Imaging Neurosci2023;
1: 1–16.
26.
ZhaoMYTongEDuarte ArmindoR, et al.
Short- and long-term MRI assessed hemodynamic changes in pediatric moyamoya patients after revascularization. J Magn Reson Imaging2024;
59: 1349–1357.
27.
ZhaoMYMezueMSegerdahlAR, et al.
A systematic study of the sensitivity of partial volume correction methods for the quantification of perfusion from pseudo-continuous arterial spin labeling MRI. NeuroImage2017;
162: 384–397.
28.
LansbergMGLeeJChristensenS, et al.
RAPID automated patient selection for reperfusion therapy. Stroke2011;
42: 1608–1614.
29.
SmithSMJenkinsonMWoolrichMW, et al.
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage2004;
23 Suppl 1: S208–S219.
30.
DesikanRSSégonneFFischlB, et al.
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage2006;
31: 968–980.
31.
SmirnovN.Table for estimating the goodness of fit of empirical distributions. Ann Math Statist1948;
19: 279–281.
32.
RaoVLProloLMSantoroJD, et al.
Acetazolamide-challenged arterial spin labeling detects augmented cerebrovascular reserve after surgery for moyamoya. Stroke2022;
53: 1354–1362. STROKEAHA.121.036616.
33.
LiuPLiuGPinhoMC, et al.
Cerebrovascular reactivity mapping using resting-state BOLD functional MRI in healthy adults and patients with moyamoya disease. Radiology2021;
299: 419–425.
34.
TakiYHashizumeHSassaY, et al.
Gender differences in partial-volume corrected brain perfusion using brain MRI in healthy children. NeuroImage2011;
58: 709–715.
35.
BolarDSGagoskiBOrbachDB, et al.
Comparison of CBF measured with combined velocity-selective arterial spin-labeling and pulsed arterial spin-labeling to blood flow patterns assessed by conventional angiography in pediatric moyamoya. AJNR Am J Neuroradiol2019;
40: 1842–1849.
36.
Hernandez-GarciaLAramendía-VidaurretaVBolarDS, et al.
Recent technical developments in ASL: a review of the state of the art. Magn Reson Med2022;
88: 2021–2042.
37.
ShiroishiMSCastellazziGBoxermanJL, et al.
Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging. J Magn Reson Imaging2014;
00: 296–313.
38.
CalamanteFChristensenSDesmondPM, et al.
The physiological significance of the time-to-maximum (tmax) parameter in perfusion MRI. Stroke2010;
41: 1169–1174.
39.
SeoYSLeeSChoiYH, et al.
Monitoring posterior cerebral perfusion changes with dynamic susceptibility contrast-enhanced perfusion MRI after anterior revascularization surgery in pediatric moyamoya disease. Korean J Radiol2023;
24: 784–794.
40.
LeeMZaharchukGGuzmanR, et al.
Quantitative hemodynamic studies in moyamoya disease. FOC2009;
26: E5.
41.
NewbouldRDSkareSTJochimsenTH, et al.
Perfusion mapping with multiecho multishot parallel imaging EPI. Magn Reson Med2007;
58: 70–81.
42.
QinQAlsopDCBolarDS, ISMRMPerfusion Study Groupet al.
Velocity-selective arterial spin labeling perfusion MRI: a review of the state of the art and recommendations for clinical implementation. Magn Reson Med2022;
88: 1528–1547.
43.
ScottRMSmithER.Moyamoya disease and moyamoya syndrome. N Engl J Med2009;
360: 1226–1237.
44.
KorogluADemirbilekSTeksanH, et al.
Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth2005;
94: 821–824.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
